Development and Online Evaluation of an Online Course for Parasomnias

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of Manitoba

About this trial

Parasomnias are unwanted events during sleep. These refer to sleep terrors, sleepwalking, sleep eating, nightmares, and movement during REM sleep. There are few systematic behavioral treatments for these problems and individuals with them often receive little education about self-management. This research examines and evaluates the effectiveness of a 4 week online course providing education and guidance about managing parasomnias. The primary outcomes are improvement in parasomnia frequency and distress. The secondary outcomes are improvements in work and social adjustment, mood, anxiety, stress level, fatigue, sleepiness, insomnia, and cognitive interference.

Eligibility criteria

Qualifiers

physician referred for parasomnia

meet criteria for parasomnia on the Structured Clinical Interview for Sleep Disorders (SCISD-R)

age >= 18 years

parasomnia duration >= 6 months

Disqualifiers

currently taking one of Lithium, Thioridazine, Chlorpromazine, Perphenazine, Methaqualone, Amitriptyline, Selective Serotonin Re-Uptake Inhibitors, Serotonin and Norepinephrine Re-Uptake inhibitors, or Zopiclone

seizure or major neurological disorder

untreated sleep apnea, restless legs syndrome, or narcolepsy

Trial design

Treatments tested in this trial

  • Parasomnia Education
  • Sleep Hygiene Control

Treatment groups

20 Participants
are divided into 2 treatment groups

Sponsors and collaborators